Aminoglycoside antibiotic (tobramycin) / Glycopeptide antibiotic (vancomycin)

This page covers all Aminoglycoside antibiotic (tobramycin) / Glycopeptide antibiotic (vancomycin) drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial 30S ribosomal subunit (tobramycin) / Bacterial cell wall peptidoglycan (vancomycin), Taste receptor type 2 member 20.

Targets

Bacterial 30S ribosomal subunit (tobramycin) / Bacterial cell wall peptidoglycan (vancomycin) · Taste receptor type 2 member 20

Marketed (2)

• Aerosolized Tobramycin or Vancomycin · Wright State University · Infectious Disease / Pulmonology
  Aerosolized aminoglycoside or glycopeptide antibiotics are inhaled directly into the lungs to achieve high local concentrations that kill susceptible bacteria in respiratory infections.
• Vantobra · Pfizer · Metabolic

Patent intelligence

• tobramycin patent landscape — aggregated cliff calendar, attackable patents, originator estates